Taiwan FDA registration d97f6826b8002c0432627b58d385874b

Recording of prothrombin pars and salivary liquefied glycochain antigen controls

TW: 錄秘帕斯異常凝血酶原和涎液化糖鏈抗原對照品

Taiwan·Risk Class 2·FUJIREBIO INC. SAGAMIHARA FACILITY.·Registered Aug 14, 2014 – Aug 14, 2029Active

Registration details

Analysis ID: d97f6826b8002c0432627b58d385874b
Customs Code: DHA05602650907

Company information

Manufacturer: FUJIREBIO INC. SAGAMIHARA FACILITY.
Manufacturer Country: Japan
Authorized Representative: Grand Marquis IVD CO., LTD.

Product details

Intended Use: Quality control serum used to monitor the accuracy of experimental test procedures when using the Secret Paz system for the analysis of abnormal prothrombin and salivary liquefied glycochain antigen.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1660 Quality control materials (analytical and non-analytical)
Import Information: import

Dates and status

Registration Date: Aug 14, 2014
Expiry Date: Aug 14, 2029

About this record

Access comprehensive regulatory information for Recording of prothrombin pars and salivary liquefied glycochain antigen controls in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d97f6826b8002c0432627b58d385874b and manufactured by FUJIREBIO INC. SAGAMIHARA FACILITY.. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.